Ibandronate is an osteoporosis medication that is used in postmenopausal women. Besides slowing the breakdown of bones, the drug can also increase bone mineral density in women with risk factors for osteoporosis. While the tablets are taken once a month, the injectable form is only administered once every three months. Side effects of ibandronate may include heartburn, indigestion, and diarrhea.
What Is Ibandronate?
Ibandronate sodium (Boniva®) is a prescription medication used to both treat and prevent osteoporosis in postmenopausal women. It can be taken just once a month.
As with any medicine, side effects are possible with ibandronate. However, not everyone who takes the drug will experience side effects. In fact, most people tolerate it quite well. If side effects do occur, in most cases, they are minor and either require no treatment or can easily be treated by you or your healthcare provider. Serious side effects are less common.
Common side effects of ibandronate include, but are not limited to:
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Boniva [package insert]. South San Francisco, CA: Genentech, Inc.;2011 January.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed April 6, 2012.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click